Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Tuberculosis (Edinburgh, Scotland)|April 13, 2010
Early clinical development of anti-tuberculosis drugs: science, statistics and sterilizing activityGeraint R Davies
Current Opinion in Infectious Diseases|January 31, 2023
Update on drug treatments for multidrug resistant tuberculosisGeraint R Davies, Stephen Aston
The Open Infectious Diseases Journal|July 2, 2013
Assessment of the Efficacy of New Anti-Tuberculosis DrugsDenis A Mitchison, Geraint R Davies
Clinical Pharmacology and Therapeutics|April 10, 2021
The Treatment of TuberculosisCharles A Peloquin, Geraint R Davies
The Cochrane Database of Systematic Reviews|June 8, 2013
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)Lilia E Ziganshina, Albina F Titarenko, Geraint R Davies
Current Respiratory Medicine Reviews|April 1, 2014
Recent advances in tuberculosis: New drugs and treatment regimensDerek J Sloan, Geraint R Davies, Saye H Khoo
Antimicrobial Agents and Chemotherapy|August 31, 2006
Use of nonlinear mixed-effects analysis for improved precision of early pharmacodynamic measures in tuberculosis treatmentGeraint R Davies, Richard Brindle, Saye H Khoo, et al.
Systematic Reviews|December 19, 2019
The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocolJames D Millard, Elizabeth A Mackay, Laura J Bonnett, et al.
Trials|November 19, 2025
Protocol for the development of a Core Outcome Set (COS) for reporting outcomes of clinical trials of anti-tuberculosis treatment in adults with pulmonary tuberculosisRebecca Thomas, Nicola L Harman, Paula R Williamson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2017
Comparing the Efficacy of Drug Regimens for Pulmonary Tuberculosis: Meta-analysis of Endpoints in Early-Phase Clinical TrialsLaura J Bonnett, Gie Ken-Dror, Gavin C K W Koh, et al.
Pageof 4